The validation of a novel method combining both HER2 immunohistochemistry and HER2 dual-colour silver in situ hybridization on one slide for gastric carcinoma testing

被引:0
作者
Dominique Werner
Achim Battmann
Kristina Steinmetz
Tobin Jones
Tiffany Lamb
Michele Martinez
Hans-Michael Altmannsberger
Salah-Eddin Al-Batran
机构
[1] UCT-University Cancer Center Frankfurt,Institute of Clinical Cancer Research (IKF) at Krankenhaus Nordwest
[2] Institute of Pathology at Krankenhaus Nordwest,Ventana Medical System
[3] Roche Pharma,undefined
[4] lnc./Roche Tissue Diagnostics,undefined
来源
Journal of Translational Medicine | / 12卷
关键词
Gastric cancer; HER2; Immunohistochemistry; Silver in situ hybridization; Gene-protein assay;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 275 条
[1]  
Schuell B(2006)HER2/neu protein expression in colorectal cancer BMC Cancer 6 123-1531
[2]  
Gruenberger T(2005)Cox-2 and Her2/neu co-expression in invasive bladder cancer Int J Oncol 26 1525-3946
[3]  
Scheithauer W(1993)Serum levels of HER-2 neu (C-erbB) correlate with overexpression of p185(neu) in human ovarian cancer Cancer 71 3942-185
[4]  
Zielinski C(1992)HER-2/neu expression: a major prognostic factor in endometrial cancer Gynecol Oncol 47 179-562
[5]  
Wrba F(2001)Protein overexpression and gene amplification of c-erb B-2 in pulmonary carcinomas: a comparative immunohistochemical and fluorescence in situ hybridization study Mod Pathol 14 556-639
[6]  
Eltze E(1994)ERBB2 (HER2/neu) oncogene is frequentlyamplified in squamous cell carcinoma of the uterine cervix Cancer Res 54 637-1270
[7]  
Wülfing C(1995)HER-2/neu oncogene characterization in head and neck squamous cell carcinoma Arch Otolaryngol Head Neck Surg 121 1265-697
[8]  
Von Struensee D(2010)Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Lancet 376 687-854
[9]  
Piechota H(2011)HER-2/neu testing and therapy in gastroesophageal adenocarcinoma Patholog Res Int 2011 674182-857
[10]  
Buerger H(2002)Real-world performance of HER2 testing-National Surgical Adjuvant Breast and Bowel Project experience J Natl Cancer Inst 94 852-582